The effectiveness of clinical guideline implementation strategies in oncology-a systematic review.

Behaviour Clinical practice guideline Guideline adherence Healthcare professionals Implementation Oncology Patient-relevant outcomes

Journal

BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677

Informations de publication

Date de publication:
06 Apr 2023
Historique:
received: 16 09 2022
accepted: 15 02 2023
medline: 10 4 2023
entrez: 6 4 2023
pubmed: 7 4 2023
Statut: epublish

Résumé

Guideline recommendations do not necessarily translate into changes in clinical practice behaviour or better patient outcomes. This systematic review aims to identify recent clinical guideline implementation strategies in oncology and to determine their effect primarily on patient-relevant outcomes and secondarily on healthcare professionals' adherence. A systematic search of five electronic databases (PubMed, Web of Science, GIN, CENTRAL, CINAHL) was conducted on 16 december 2022. Randomized controlled trials (RCTs) and non-randomized studies of interventions (NRSIs) assessing the effectiveness of guideline implementation strategies on patient-relevant outcomes (overall survival, quality of life, adverse events) and healthcare professionals' adherence outcomes (screening, referral, prescribing, attitudes, knowledge) in the oncological setting were targeted. The Cochrane risk-of-bias tool and the ROBINS-I tool were used for assessing the risk of bias. Certainty in the evidence was evaluated according to GRADE recommendations. This review was prospectively registered in the International Prospective Register of Systematic Reviews (PROSPERO) with the identification number CRD42021268593. Of 1326 records identified, nine studies, five cluster RCTs and four controlled before-and after studies, were included in the narrative synthesis. All nine studies assess the effect of multi-component interventions in 3577 cancer patients and more than 450 oncologists, nurses and medical staff. Educational meetings combined with materials, opinion leaders, audit and feedback, a tailored intervention or academic detailing may have little to no effect on overall survival, quality of life and adverse events of cancer patients compared to no intervention, however, the evidence is either uncertain or very uncertain. Multi-component interventions may increase or slightly increase guideline adherence regarding screening, referral and prescribing behaviour of healthcare professionals according to guidelines, but the certainty in evidence is low. The interventions may have little to no effect on attitudes and knowledge of healthcare professionals, still, the evidence is very uncertain. Knowledge and skill accumulation through team-oriented or online educational training and dissemination of materials embedded in multi-component interventions seem to be the most frequently researched guideline implementation strategies in oncology recently. This systematic review provides an overview of recent guideline implementation strategies in oncology, encourages future implementation research in this area and informs policymakers and professional organisations on the development and adoption of implementation strategies.

Identifiants

pubmed: 37024867
doi: 10.1186/s12913-023-09189-x
pii: 10.1186/s12913-023-09189-x
pmc: PMC10080872
doi:

Types de publication

Review Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

347

Informations de copyright

© 2023. The Author(s).

Références

BMC Cancer. 2021 Mar 6;21(1):236
pubmed: 33676431
BMJ. 1996 Jan 13;312(7023):71-2
pubmed: 8555924
J Clin Epidemiol. 2020 Mar;119:126-135
pubmed: 31711912
BMC Health Serv Res. 2020 Oct 7;20(1):920
pubmed: 33028324
Implement Sci. 2011 Apr 23;6:42
pubmed: 21513547
Lancet. 2003 Oct 11;362(9391):1225-30
pubmed: 14568747
Health Technol Assess. 2004 Feb;8(6):iii-iv, 1-72
pubmed: 14960256
Lancet. 2021 Nov 20;398(10314):1894-1904
pubmed: 34741815
J Dtsch Dermatol Ges. 2020 Aug;18(8):848-857
pubmed: 32578392
BMJ Open. 2021 Jan 19;11(1):e039770
pubmed: 33468525
JAMA Netw Open. 2022 Feb 1;5(2):e220060
pubmed: 35188554
Trials. 2015 Mar 24;16:109
pubmed: 25873142
BMC Health Serv Res. 2018 Jul 16;18(1):558
pubmed: 30012122
Implement Sci. 2013 Mar 15;8:32
pubmed: 23497520
Cochrane Database Syst Rev. 2003;(3):CD000259
pubmed: 12917891
Clin J Oncol Nurs. 2022 Feb 1;26(1):E7-E13
pubmed: 35073299
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Health Educ Res. 2005 Jun;20(3):275-90
pubmed: 15632099
Int J Qual Health Care. 2016 Feb;28(1):122-8
pubmed: 26796486
Implement Sci. 2018 Mar 12;13(1):43
pubmed: 29530071
Implement Sci. 2011 Dec 06;6:126
pubmed: 22142327
Implement Sci. 2019 Dec 17;14(1):106
pubmed: 31847876
Health Policy. 2012 Oct;107(2-3):168-83
pubmed: 22940062
J Eval Clin Pract. 2012 Aug;18(4):841-7
pubmed: 21518400
Cochrane Database Syst Rev. 2011 Aug 10;(8):CD000125
pubmed: 21833939
Qual Saf Health Care. 2008 Aug;17(4):296-300
pubmed: 18678729
ESMO Open. 2018 Jul 25;3(5):e000385
pubmed: 30094071
Implement Sci. 2015 Jul 30;10:106
pubmed: 26223232
Trials. 2021 Jul 15;22(1):452
pubmed: 34266464
Pain Med. 2013 Jul;14(7):971-81
pubmed: 23577878
Pain Manag Nurs. 2017 Apr;18(2):75-89
pubmed: 28363326
Contemp Clin Trials. 2020 Apr;91:105963
pubmed: 32087340
J R Soc Med. 2011 Dec;104(12):510-20
pubmed: 22179294
Nutrients. 2021 Jul 09;13(7):
pubmed: 34371859
J Gen Intern Med. 2018 Jul;33(7):1142-1154
pubmed: 29728892
BMJ Qual Saf. 2022 Aug;31(8):579-589
pubmed: 34607914
Med Care. 2001 Aug;39(8 Suppl 2):II46-54
pubmed: 11583121
Cochrane Database Syst Rev. 2019 Dec 18;12:CD001174
pubmed: 31858588
J Contin Educ Nurs. 2018 Apr 1;49(4):178-185
pubmed: 29596705
Cochrane Database Syst Rev. 2012 Oct 17;10:CD004398
pubmed: 23076904
Implement Sci. 2016 Sep 02;11(1):118
pubmed: 27590603
J Oncol Pharm Pract. 2012 Sep;18(3):333-42
pubmed: 22298660
BMJ Open. 2018 Nov 25;8(11):e017572
pubmed: 30478101
Transl Behav Med. 2018 Mar 1;8(2):166-174
pubmed: 29365187
Implement Sci. 2012 Apr 24;7:38
pubmed: 22531013
Int J Nurs Stud. 2020 Nov;111:103748
pubmed: 32961463
Implement Sci. 2020 May 27;15(1):39
pubmed: 32460797
Ann Intern Med. 2000 Aug 15;133(4):317-8
pubmed: 10929192
Oncol Nurs Forum. 2019 Mar 1;46(2):198-207
pubmed: 30767958
Implement Sci. 2020 Jun 3;15(1):41
pubmed: 32493348
Ann Oncol. 2008 Dec;19(12):2067-78
pubmed: 18662954
BMJ Open. 2017 Oct 06;7(10):e016347
pubmed: 28988170
Cochrane Database Syst Rev. 2017 Jul 06;7:CD001175
pubmed: 28681432
Contemp Clin Trials. 2021 Aug;107:106448
pubmed: 34023515

Auteurs

Ana-Mihaela Bora (AM)

Evidence-Based Medicine, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany. ana-mihaela.bora@uk-koeln.de.

Vanessa Piechotta (V)

Evidence-Based Medicine, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Nina Kreuzberger (N)

Evidence-Based Medicine, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Ina Monsef (I)

Evidence-Based Medicine, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Andreas Wender (A)

Evidence-Based Medicine, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Markus Follmann (M)

German Cancer Society, Berlin, Germany.

Monika Nothacker (M)

Institute for Medical Knowledge Management, Association of the Scientific Medical Societies in Germany, C/O Faculty of Medicine, Philipps University Marburg, Marburg, Germany.

Nicole Skoetz (N)

Evidence-Based Medicine, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH